Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026).

Annals of internal medicine·2026
Same author

Global advances in health artificial intelligence: a workforce imperative.

Lancet (London, England)·2026
Same author

Nurse and Social Worker Perceptions of Early Adoption of VA's Nationally Scaled Care Coordination Initiative.

Medical care research and review : MCRR·2026
Same author

Patient-Reported Diagnostic Excellence in Emergency Care: Cross-Site Score Variation and Purpose-Dependent Interpretation.

Joint Commission journal on quality and patient safety·2026
Same author

Dialysis Facility Closures in the US From 2018 to 2024: A Serial Cross-Sectional Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 4).

Annals of internal medicine·2026

Related Experiment Video

Updated: Jul 12, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Pediatric anthrax: implications for bioterrorism preparedness.

Dena M Bravata, Ewen Wang, Jon-Erik Holty

    Evidence Report/Technology Assessment
    |September 4, 2007
    PubMed
    Summary

    Pediatric anthrax presents with diverse symptoms and differs from adult cases. Early diagnosis and tailored treatment are crucial for improving outcomes in children with anthrax.

    More Related Videos

    Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology
    11:13

    Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology

    Published on: October 3, 2016

    Related Experiment Videos

    Last Updated: Jul 12, 2026

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
    13:47

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

    Published on: May 19, 2020

    Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology
    11:13

    Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology

    Published on: October 3, 2016

    Area of Science:

    • Pediatric Infectious Diseases
    • Bioterrorism Preparedness
    • Public Health Surveillance

    Background:

    • Anthrax is a serious infectious disease with rare but significant pediatric cases.
    • Understanding pediatric anthrax is crucial for public health preparedness and response.

    Purpose of the Study:

    • To systematically review literature on pediatric anthrax.
    • Describe clinical course, treatment responses, and predictors of mortality in children.

    Main Methods:

    • Systematic literature review of pediatric anthrax case reports (1900-2005).
    • Data abstraction on patient demographics, symptoms, disease progression, and treatments.
    • Comparison of pediatric cases with previously reviewed adult anthrax data.

    Main Results:

    • 62 pediatric anthrax case reports identified (inhalational, gastrointestinal, cutaneous, atypical).
    • Clinical presentations in children vary and differ from adults, with atypical presentations in inhalational anthrax.
    • Penicillin-based antibiotics showed a 63% survival rate; anthrax antiserum showed an 82% survival rate.

    Conclusions:

    • Pediatric anthrax exhibits a wide spectrum of clinical signs and symptoms.
    • Differences exist between pediatric and adult anthrax presentations and treatment responses.
    • Preparedness planning must specifically consider the needs of pediatric anthrax victims.